Pseudoephedrine Polistirex

CHEMBL1201483 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Pseudoephedrine polistirex is an extended-release resin complex form of pseudoephedrine that provides prolonged nasal decongestant action through controlled release of active drug from the ion-exchange resin matrix in the gastrointestinal tract. See pseudoephedrine for complete pharmacological details.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Pseudoephedrine polistirex is an extended-release resin complex form of pseudoephedrine that provides prolonged nasal decongestant action through controlled release of active drug from the ion-exchange resin matrix in the gastrointestinal tract. See pseudoephedrine for complete pharmacological details.

Yes, Pseudoephedrine Polistirex is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201483. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.